Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2004 1
2005 1
2006 1
2023 0

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
Alternate paclitaxel-gemcitabine and paclitaxel-vinorelbine biweekly administration in non-small cell lung cancer patients: a phase II study.
Dimitroulis J, Toubis M, Antoniou D, Marosis C, Armenaki U, Stathopoulos GP, Giamboudakis P, Veslemes M, Michalopoulou P, Christou F, Georgatou N, Grigoratou T, Karaindros D, Katis K; SOLCA Study Group. Dimitroulis J, et al. Among authors: grigoratou t. Anticancer Res. 2006 Mar-Apr;26(2B):1397-402. Anticancer Res. 2006. PMID: 16619550 Free article. Clinical Trial.
Comparison of docetaxel/cisplatin to docetaxel/gemcitabine as first-line treatment of advanced non-small cell lung cancer: early results of a randomized trial.
Georgoulias V, Samonis G, Papadakis E, Alexopoulos A, Tsiafaki X, Rapti A, Veslemes M, Grigoratou T, Palamidas P, Kouroussis C, Mavroudis D, Kakolyris S, Giannakakis T, Vlachonikolis J; Greek Cooperative Group for Lung Cancer. Georgoulias V, et al. Among authors: grigoratou t. Lung Cancer. 2001 Dec;34 Suppl 4:S47-51. doi: 10.1016/s0169-5002(01)00417-2. Lung Cancer. 2001. PMID: 11742702 Clinical Trial.
Front-line paclitaxel-vinorelbine versus paclitaxel-carboplatin in patients with advanced non-small-cell lung cancer: a randomized phase III trial.
Stathopoulos GP, Veslemes M, Georgatou N, Antoniou D, Giamboudakis P, Katis K, Tsavdaridis D, Rigatos SK, Dimitroulis I, Bastani S, Loukides S, Vergos K, Marossis K, Grigoratou T, Kalatzi E, Charalambatou M, Paspalli A, Michalopoulou P, Stoka M, Gerogianni A. Stathopoulos GP, et al. Among authors: grigoratou t. Ann Oncol. 2004 Jul;15(7):1048-55. doi: 10.1093/annonc/mdh260. Ann Oncol. 2004. PMID: 15205198 Free article. Clinical Trial.